Literature DB >> 19922464

Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population.

M Xiao1, F Qi, X Chen, Z Luo, L Zhang, C Zheng, S Hu, X Jiang, M Zhou, J Tang.   

Abstract

Cytotoxic T-lymphocyte antigen 4 (CTLA-4; CD152) is a secondary receptor of B7 (CD80 and CD86) and shares homology with the CD28 receptor. Although the structures of CTLA-4 and CD28 are very similar, they deliver different costimulatory signals. A functional polymorphism in CTLA-4 exon 1 position +49 that can affect the T-cell response has been reported by several groups. Previous case-control studies also revealed this polymorphism contribute to the risk of autoimmune diseases and common cancers. However, the relationship between CTLA-4 functional polymorphism and nasopharyngeal carcinoma (NPC) susceptibility has not yet been explored. In this study, we performed a case-control study in a Chinese population. Our result showed that the CTLA-4 +49 A>G polymorphism is associated with NPC susceptibility. The subjects carrying the CTLA-4 +49 AA genotype have a approximately 1.8-fold increased risk of NPC (adjust OR 1.83; 95% CI, 1.16-2.93) when compared with the GG genotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922464     DOI: 10.1111/j.1744-313X.2009.00888.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  9 in total

1.  Genetic variation in the NBS1 gene is associated with hepatic cancer risk in a Chinese population.

Authors:  Ming-De Huang; Xiao-Fei Chen; Gang Xu; Qing-Quan Wu; Jian-Huai Zhang; Guo-Feng Chen; Yong Cai; Fu-Zhen Qi
Journal:  DNA Cell Biol       Date:  2011-11-09       Impact factor: 3.311

Review 2.  Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.

Authors:  Allan Hildesheim; Cheng-Ping Wang
Journal:  Semin Cancer Biol       Date:  2012-01-25       Impact factor: 15.707

3.  Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk.

Authors:  Hongyuan Wan; Hangsheng Zhou; Yanyan Feng; Yongquan Chen; Lijie Zhu; Yuanyuan Mi
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

4.  Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies.

Authors:  Lu Wang; Zhiwei Jiang; Hao Qiu; Weifeng Tang; Tanghai Duan; Lixin Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

5.  Association between the Cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis.

Authors:  Jian Zheng; Xiao Yu; Lan Jiang; Mang Xiao; Bing Bai; Jiachun Lu; Yifeng Zhou
Journal:  BMC Cancer       Date:  2010-10-04       Impact factor: 4.430

Review 6.  The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma.

Authors:  Maria Li Lung; Arthur Kwok Leung Cheung; Josephine Mun Yee Ko; Hong Lok Lung; Yue Cheng; Wei Dai
Journal:  Chin J Cancer       Date:  2014-11

7.  Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma.

Authors:  Pei-Yu Huang; Shan-Shan Guo; Yu Zhang; Jia-Bin Lu; Qiu-Yan Chen; Lin-Quan Tang; Lu Zhang; Li-Ting Liu; Li Zhang; Hai-Qiang Mai
Journal:  Oncotarget       Date:  2016-03-15

Review 8.  Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma.

Authors:  Xinmeng Qi; Bo Jia; Xue Zhao; Dan Yu
Journal:  Onco Targets Ther       Date:  2017-12-01       Impact factor: 4.147

Review 9.  Advanced Nasopharyngeal Carcinoma: Current and Emerging Treatment Options.

Authors:  Rina Jiromaru; Takashi Nakagawa; Ryuji Yasumatsu
Journal:  Cancer Manag Res       Date:  2022-09-12       Impact factor: 3.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.